
Scott Karolchyk Ms Rph Fapc
An accomplished pharmaceutical scientist, focused on biopharmaceutical and physical sciences, and product development leader with extensive experience in... | United States
*50 free lookup(s) per month.
No credit card required.
Scott Karolchyk Ms Rph Fapc’s Emails sc****@me****.com
Scott Karolchyk Ms Rph Fapc’s Phone Numbers No phone number available.
Social Media
Scott Karolchyk Ms Rph Fapc’s Location United States
Scott Karolchyk Ms Rph Fapc’s Expertise An accomplished pharmaceutical scientist, focused on biopharmaceutical and physical sciences, and product development leader with extensive experience in pharmaceutical formulation design, neuropharmacology, ophthalmic formulations, oral dosage forms, surface phenomena, compounded preparation research, and strategic management. Key research and product focus is enhanced bioavailability utilizing nanotechnology. Patent granted for an emulsified, water soluble cannabis/hemp cannabinoid/terpene powder on 4/20/21. Three US Patents on TriMoxi ophthalmic injection and its combination ophthalmic topicals. Granted over 40 additional drug formulation and methodology related patents. Proactive and tenacious in applying knowledge to project initiatives, utilizing communication across divisions to influence and drive project teams with a particular focus on successful delivery of new formulations, clinical trial proposals and supplies, regulatory submissions and commercial deliverables.
Scott Karolchyk Ms Rph Fapc’s Current Industry Medpharm Research
Scott
Karolchyk Ms Rph Fapc’s Prior Industry
Novel Drug Solutions
|
Qmedrx
|
Medpharm Research
Not the Scott Karolchyk Ms Rph Fapc you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Medpharm Research
Director Of Formulation Development
Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Qmedrx
Vp Of Formulations
Mon Sep 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Apr 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Novel Drug Solutions
Principal
Sun Apr 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Present